Literature DB >> 1952870

Lack of homology of enterococci which have high-level resistance to trimethoprim with the dfrA gene of Staphylococcus aureus.

M Frosolono1, S L Hodel-Christian, B E Murray.   

Abstract

Multiresistant enterococci were tested for susceptibility to trimethoprim (TMP). Although most enterococci are inhibited by less than or equal to 1.0 microgram/ml, the MICs for 7 of 29 selected multiresistant isolates were greater than or equal to 8 micrograms/ml, including for two beta-lactamase positive (Bla+) strains, for which the MICs of TMP were greater than 1,000 micrograms/ml, and for another Bla+ strain, for which the MIC was 128 micrograms/ml. None of five isolates tested transferred TMP resistance and none of the resistant isolates hybridized to the dfrA gene of Staphylococcus aureus. Whether TMP resistance in enterococci is due to a mutation(s) or to acquisition of a new gene is not known. Acquisition of resistance to TMP is another example of the multiple antimicrobial resistance typically displayed by enterococci.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1952870      PMCID: PMC245296          DOI: 10.1128/AAC.35.9.1928

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Comparison of two beta-lactamase-producing strains of Streptococcus faecalis.

Authors:  B E Murray; D A Church; A Wanger; K Zscheck; M E Levison; M J Ingerman; E Abrutyn; B Mederski-Samoraj
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

2.  In vitro studies of plasmid-mediated penicillinase from Streptococcus faecalis suggest a staphylococcal origin.

Authors:  B E Murray; B Mederski-Samoraj; S K Foster; J L Brunton; P Harford
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

3.  Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci.

Authors:  A Najjar; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

4.  Enterococci from Bangkok, Thailand, with high-level resistance to currently available aminoglycosides.

Authors:  B E Murray; J Tsao; J Panida
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

5.  Reversal of activity of trimethoprim against gram-positive cocci by thymidine, thymine and 'folates'.

Authors:  J M Hamilton-Miller
Journal:  J Antimicrob Chemother       Date:  1988-07       Impact factor: 5.790

6.  Plasmids and pheromone response of the beta-lactamase producer Streptococcus (Enterococcus) faecalis HH22.

Authors:  B E Murray; F Y An; D B Clewell
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

7.  Molecular epidemiology of trimethoprim resistance among coagulase-negative staphylococci.

Authors:  D W Galetto; J L Johnston; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

8.  In vivo v in vitro susceptibility of enterococcus to trimethoprim-sulfamethoxazole. A pitfall.

Authors:  G L Goodhart
Journal:  JAMA       Date:  1984-11-16       Impact factor: 56.272

9.  Plasmid-encoded trimethoprim resistance in staphylococci.

Authors:  G L Archer; J P Coughter; J L Johnston
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

10.  Reversal of the in vitro susceptibility of enterococci to trimethoprim-sulfamethoxazole by folinic acid.

Authors:  M J Zervos; D R Schaberg
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

View more
  3 in total

1.  Characterization of dihydrofolate reductase genes from trimethoprim-susceptible and trimethoprim-resistant strains of Enterococcus faecalis.

Authors:  T M Coque; K V Singh; G M Weinstock; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

Review 2.  Trimethoprim and sulfonamide resistance.

Authors:  P Huovinen; L Sundström; G Swedberg; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

Review 3.  Resistance to tetracycline, macrolide-lincosamide-streptogramin, trimethoprim, and sulfonamide drug classes.

Authors:  Marilyn C Roberts
Journal:  Mol Biotechnol       Date:  2002-03       Impact factor: 2.695

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.